01 Feb 2016 --- A new study published in The Journal of Nutrition today shows the anti-inflammatory intestinal protection of human milk oligosaccharides can be synthetically replicated, marking an important step forward in infant formula development. The study investigated the anti-inflammatory properties of human milk oligosaccharides (HMOS), and the unique galacto-oligosaccharide (GOS) complex Bimuno, on gut inflammation using a human cell based model. Similar to human milk, both HMOS and GOS were found to directly reduce inflammation, which is considered to be essential for healthy gut development in early life.
